Results 91 to 100 of about 2,895 (162)

The dynamic distribution of genetic tandem amplifications in a heteroresistant Escherichia coli population revealed by ultra-deep long read sequencing

open access: yesNature Communications
Antibiotic heteroresistance, characterized by rare resistant subpopulations of bacteria within a susceptible main population, is associated with treatment failure and often caused by tandem amplification of resistance genes. Here, we investigated how the
Sofia Jonsson   +4 more
doaj   +1 more source

Fluoroquinolones and rifampin combination in the backdrop of heteroresistant tuberculosis

open access: yesAntimicrobial Agents and Chemotherapy
ABSTRACT The impact of heteroresistance on tuberculosis (TB) treatment outcomes is unclear, as is the role of different rifampin and isoniazid exposures on developing resistance mutations. Hollow fiber system model of TB (HFS-TB) units were inoculated with drug-susceptible Mycobacterium ...
Vanessa B. Vogensen   +9 more
openaire   +2 more sources

Heteroresistance in Mycobacterium tuberculosis: from molecular mechanisms and advanced detection to clinical implications

open access: yesFrontiers in Cellular and Infection Microbiology
Drug resistance in Mycobacterium species, particularly Mycobacterium tuberculosis, remains a protracted and severe challenge to global public health.
Shibo Liu   +3 more
doaj   +1 more source

Progress in the Study of Polymyxin Heteroresistance Molecular Mechanisms

open access: yesXiehe Yixue Zazhi
Polymyxins, a class of cyclic peptide antibiotics, have become the last line of defense against gram-negative bacterial infections as the number of multidrug-resistant bacteria continues to rise.
LI Yanbing, ZHOU Menglan, XU Yingchun
doaj   +1 more source

Genetic Evaluation of Heteroresistance among Carbapenem-Susceptible Clinical Isolates of Enterobacterales

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology
Carbapenems currently serve as the last line of defense when treating serious infections caused by multidrug-resistant Enterobacterales species; however, heteroresistance of these species is thought to cause failure in the treatment with these broad ...
İpek Koçer   +2 more
doaj   +1 more source

Three concurrent mechanisms generate gene copy number variation and transient antibiotic heteroresistance

open access: yesNature Communications
Heteroresistance is a medically relevant phenotype where small antibiotic-resistant subpopulations coexist within predominantly susceptible bacterial populations. Heteroresistance reduces treatment efficacy across diverse bacterial species and antibiotic
Hervé Nicoloff   +3 more
doaj   +1 more source

Heterogeneous subpopulations in Escherichia coli strains acquire adaptive resistance to imipenem treatment through rapid transcriptional regulation

open access: yesFrontiers in Cellular and Infection Microbiology
IntroductionHeteroresistance is a well-known phenomenon contributing to treatment failure in bacterial infections. Previous research has traditionally linked it to genetic mechanisms, emphasizing fixed subpopulations with specific resistance mutations ...
YunTao Luo   +6 more
doaj   +1 more source

Investigation of colistin heteroresistance and the colistin resistance genes mcr-1 to mcr-5 in Escherichia coli and Klebsiella pneumoniae isolates in a tertiary hospital in Turkey

open access: yesJournal of Infection in Developing Countries
Introduction: Heteroresistance is not detected by traditional antimicrobial susceptibility testing methods and may lead to treatment failures. Investigating the presence of plasmid-mediated colistin resistance genes is important because of the ...
Erkut Afyoncu, Canan Eryıldız
doaj   +1 more source

Investigation of bedaquiline heteroresistance among Mycobacterium tuberculosis isolates from Pakistan

open access: yesMicrobiology Spectrum
Bedaquiline is a key drug recommended by the WHO for the treatment of multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant (XDR) TB, and its use could potentially shorten treatment duration with improved outcomes.
Faiqa Rashid   +3 more
doaj   +1 more source

Placing in-vitro heteroresistance in the context of clinical results [PDF]

open access: yesThe Lancet Infectious Diseases, 2021
Matteo, Bassetti   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy